MedPath

A study to test different doses of BI 765049 in people with advanced cancer of the colon, rectum, stomach, or pancreas

Conditions
colorectal carcinoma (CRC)
Registration Number
2024-519301-36-00
Lead Sponsor
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath